MME and renal cell carcinoma: The data obtained did not highlight on any occasion an immunohistochemical profile coherent with that proposed for RCC-FMS (diffuse CK7+, diffuse membranous or cup-shaped CAIX+, CD10+, CK34betaE12+) [13].